Ameriprise Financial Inc Vanda Pharmaceuticals Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 241,986 shares of VNDA stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
241,986
Previous 243,991 0.82%
Holding current value
$1.11 Million
Previous $1.38 Million 17.71%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.61 - $6.34 $9,243 - $12,711
-2,005 Reduced 0.82%
241,986 $1.13 Million
Q2 2024

Aug 14, 2024
SELL
$3.91 - $6.5 $977 - $1,625
-250 Reduced 0.1%
243,991 $1.38 Million
Q1 2024

May 15, 2024
SELL
$3.47 - $4.61 $190,787 - $253,467
-54,982 Reduced 18.37%
244,241 $1 Million
Q4 2023

Feb 14, 2024
SELL
$3.38 - $4.58 $1.12 Million - $1.52 Million
-330,927 Reduced 52.52%
299,223 $1.26 Million
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $1.88 Million - $2.88 Million
-438,806 Reduced 41.05%
630,150 $2.72 Million
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $459,674 - $541,481
77,911 Added 7.86%
1,068,956 $7.04 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $920,164 - $1.19 Million
148,894 Added 17.68%
991,045 $6.73 Million
Q4 2022

Feb 14, 2023
SELL
$6.87 - $10.96 $482,081 - $769,085
-70,172 Reduced 7.69%
842,151 $6.22 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $1.23 Million - $1.53 Million
129,898 Added 16.6%
912,323 $9.02 Million
Q2 2022

Aug 15, 2022
SELL
$9.31 - $11.84 $152,022 - $193,335
-16,329 Reduced 2.04%
782,425 $8.53 Million
Q1 2022

May 16, 2022
BUY
$10.84 - $16.55 $427,887 - $653,278
39,473 Added 5.2%
798,754 $9.03 Million
Q4 2021

Feb 14, 2022
BUY
$15.69 - $21.14 $6 Million - $8.09 Million
382,668 Added 101.61%
759,281 $11.9 Million
Q3 2021

Nov 15, 2021
BUY
$15.35 - $21.27 $129,185 - $179,008
8,416 Added 2.29%
376,613 $6.45 Million
Q2 2021

Aug 16, 2021
BUY
$15.71 - $21.51 $500,991 - $685,953
31,890 Added 9.48%
368,197 $7.92 Million
Q1 2021

May 17, 2021
SELL
$13.42 - $20.28 $764,926 - $1.16 Million
-56,999 Reduced 14.49%
336,307 $5.05 Million
Q4 2020

Feb 12, 2021
SELL
$9.77 - $13.81 $651,483 - $920,878
-66,682 Reduced 14.5%
393,306 $5.17 Million
Q3 2020

Nov 16, 2020
BUY
$9.32 - $12.02 $862,752 - $1.11 Million
92,570 Added 25.19%
459,988 $4.44 Million
Q2 2020

Aug 14, 2020
SELL
$9.66 - $12.02 $45,247 - $56,301
-4,684 Reduced 1.26%
367,418 $4.2 Million
Q1 2020

May 15, 2020
BUY
$7.5 - $16.8 $128,025 - $286,776
17,070 Added 4.81%
372,102 $3.86 Million
Q4 2019

Feb 14, 2020
SELL
$12.38 - $17.47 $59,473 - $83,925
-4,804 Reduced 1.34%
355,032 $5.83 Million
Q3 2019

Nov 14, 2019
SELL
$12.27 - $15.79 $290,246 - $373,512
-23,655 Reduced 6.17%
359,836 $4.78 Million
Q2 2019

Aug 14, 2019
SELL
$13.37 - $18.85 $936,929 - $1.32 Million
-70,077 Reduced 15.45%
383,491 $5.4 Million
Q1 2019

May 15, 2019
SELL
$17.59 - $31.05 $3.06 Million - $5.4 Million
-174,031 Reduced 27.73%
453,568 $8.35 Million
Q4 2018

Feb 14, 2019
BUY
$18.97 - $31.47 $8.08 Million - $13.4 Million
426,038 Added 211.37%
627,599 $16.4 Million
Q3 2018

Nov 14, 2018
BUY
$18.25 - $23.0 $1.71 Million - $2.16 Million
93,835 Added 87.11%
201,561 $4.63 Million
Q2 2018

Aug 14, 2018
BUY
$13.95 - $19.15 $130,306 - $178,880
9,341 Added 9.49%
107,726 $2.05 Million
Q1 2018

May 15, 2018
BUY
$14.05 - $20.2 $150,882 - $216,927
10,739 Added 12.25%
98,385 $1.66 Million
Q4 2017

Feb 12, 2018
SELL
$12.85 - $18.1 $6,604 - $9,303
-514 Reduced 0.58%
87,646 $1.33 Million
Q3 2017

Nov 07, 2017
BUY
$15.4 - $18.85 $1.36 Million - $1.66 Million
88,160
88,160 $1.58 Million

Others Institutions Holding VNDA

# of Institutions
159
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $260M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email